Image de couverture de livre

GPCR and CDK proteins' target-drug interactions, HIV and COV proteins' target-target interactions, and GPCR and CDK proteins' mutated sequences

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Harrouche, Oussama
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

GPCR‐G protein selectivity revealed by structural pharmacology
par: Sarah M. Bernhard, et autres
Publié: (2024)

GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems
par: Tahmid Faisal, et autres
Publié: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
par: Mamoor, Shahan
Publié: (2025)

Unlocking mitochondrial drug targets: The importance of mitochondrial transport proteins
par: Charlotte A. Hoogstraten, et autres
Publié: (2024)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
par: Mamoor, Shahan
Publié: (2025)

IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review.
par: Liu, Yan-Jun, et autres
Publié: (2025)

Input files, parameters, and scripts used for the computational mapping and targeting of BK channel protein–protein interactions in breast cancer
par: Vergara-Jaque, Ariela, et autres
Publié: (2026)

Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
par: Marta Lopez‐Balastegui, et autres
Publié: (2024)

Engineering IGF2 for Lysosome‐targeting chimeras development to target drug‐resistant membrane proteins in tumor therapy
par: Yanchao Pan, et autres
Publié: (2025)

Discovering new mode‐of‐action pesticide leads inhibiting protein–protein interactions: example targeting plant O ‐acetylserine sulfhydrylase
par: Rotem Shelly Ben‐Shushan, et autres
Publié: (2024)

GPCR-Filter: a deep learning framework for efficient and precise GPCR modulator discovery
par: Ning, Jingjie, et autres
Publié: (2026)

ApexGen: Simultaneous design of peptide binder sequence and structure for target proteins
par: Xia, Xiaoqiong, et autres
Publié: (2025)

Unlocking GPCR–ligand interactions: Measuring binding affinities with thermal shift assay
par: Dmitrii Dashevskii, et autres
Publié: (2025)

Heterogeneous networks in drug-target interaction prediction
par: Molaee, Mohammad, et autres
Publié: (2025)

CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma
par: Johannes Steinhart, et autres
Publié: (2024)

Development of tau targeted protein degraders for Alzheimer disease
par: Lisha Wang, et autres
Publié: (2024)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
par: Mamoor, Shahan
Publié: (2026)

Lysosome‐targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins
par: Qingquan Zheng, et autres
Publié: (2024)

Privileged proteins with a second residence: dual targeting and conditional re‐routing of mitochondrial proteins
par: Ophry Pines, et autres
Publié: (2024)

Mechanisms governing GPCR anterograde transport
par: Kevin Assoumou, et autres
Publié: (2025)

GPCR microswitch analysis scripts and data
par: Ji, Jingjing, et autres
Publié: (2026)

Computational modeling and experimental validation of the interaction between tumor biomarker mesothelin and an engineered targeting protein with therapeutic activity
par: Margherita Piccardi, et autres
Publié: (2025)

Sequence-based protein-protein interaction prediction and its applications in drug discovery
par: Charih, François, et autres
Publié: (2025)

Glycopolymers stabilize protein folding and protein–protein interactions via enthalpic interactions
par: Sabrina M. Richter, et autres
Publié: (2025)

Utilizing aptamers in targeted protein degradation strategies for disease therapy
par: Lin Li, et autres
Publié: (2025)

Theranostics targeting fibroblast activation protein in the pan‐cancer field
par: Yutao Li, et autres
Publié: (2025)

Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteins
par: Marc A. Scemama de Gialluly, et autres
Publié: (2026)

Construction of a versatile fusion protein for targeted therapy and immunotherapy
par: Xiu‐Song Huang, et autres
Publié: (2024)

The emerging role of targeted protein degradation to treat and study cancer
par: Maximillian H Brodermann, et autres
Publié: (2024)

The contribution of mRNA targeting to spatial protein localization in bacteria
par: Wenkang Shang, et autres
Publié: (2024)

Design, synthesis, and analysis of macrobicyclic peptides for targeting the Gαi protein
par: Anna Pepanian, et autres
Publié: (2024)

De novo design of protein binders targeting the human sweet taste receptor as potential sweet proteins
par: Ding, Saisai, et autres
Publié: (2026)

Structuring the GPCR Story Through the Lens of NMR
par: Arpita Prasad, et autres
Publié: (2025)

The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma
par: Ana B. Caniceiro, et autres
Publié: (2026)

Artificial intelligence streamlines scientific discovery of drug–target interactions
par: Yuxin Yang, et autres
Publié: (2025)

A large dataset curation and benchmark for drug target interaction
par: Golts, Alex, et autres
Publié: (2024)

The unfolded protein response is a potential therapeutic target in pathogenic fungi
par: Hao Zhou, et autres
Publié: (2025)

An archaeal protein nanoparticle platform for cancer cell-specific targeting and therapeutics.
par: Byun, Jun-Hwan, et autres
Publié: (2025)

Heat shock protein 90: biological functions, diseases, and therapeutic targets
par: Huiyun Wei, et autres
Publié: (2024)

Mapping protein–protein interactions by mass spectrometry
par: Xiaonan Liu, et autres
Publié: (2024)